Vitiligo patients have lower skin cancer risk, study finds

12/26/2012 | Modern Medicine

People with vitiligo were three times less likely than people who do not have the disease to develop skin cancer, a study published in the British Journal of Dermatology found. The autoimmune response triggered by vitiligo might have a protective effect against skin cancers, a researcher said. The study was based on a survey of patients with vitiligo and their partners without the disease.

View Full Article in:

Modern Medicine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD